Nuria Chic

Nuria Chic

Universitat de Barcelona - Barcelona / Spain
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4688694
University of Barcelona
person_outline Nuria Chic's MOST POPULAR ARTICLES
1-) Phase III randomized study of ribociclib and fulvestrant in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: MONALEESA-3DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, ...Journal of Clinical Oncology 36 (24), 2465-2472, 20186872018
2-) Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancerF Schettini, N Chic, F Brasó-Maristany, L Paré, T Pascual, B Conte, ...NPJ Breast Cancer 7 (1), 1-13, 20211192021
3-) Frequency and spectrum of PIK3CA somatic mutations in breast cancerO Martínez-Sáez, N Chic, T Pascual, B Adamo, M Vidal, B González-Farré, ...Breast Cancer Research 22 (1), 1-9, 20201172020
4-) Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label …A Prat, C Saura, T Pascual, C Hernando, M Muñoz, L Paré, BG Farré, ...The lancet oncology 21 (1), 33-43, 20201682020
5-) HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: a systematic review and meta-analysisF Schettini, T Pascual, B Conte, N Chic, F Brasó-Maristany, P Galván, ...Cancer treatment reviews 84, 101965, 20201392020